A detailed history of V Square Quantitative Management LLC transactions in Repligen Corp stock. As of the latest transaction made, V Square Quantitative Management LLC holds 697 shares of RGEN stock, worth $95,203. This represents 0.01% of its overall portfolio holdings.

Number of Shares
697
Previous 564 23.58%
Holding current value
$95,203
Previous $104 Million 15.3%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$120.0 - $182.95 $15,960 - $24,332
133 Added 23.58%
697 $87.9 Million
Q4 2023

Feb 21, 2024

BUY
$114.17 - $185.35 $27,971 - $45,410
245 Added 76.8%
564 $101 Million
Q2 2023

Jul 26, 2023

BUY
$138.42 - $180.31 $44,155 - $57,518
319 New
319 $45.1 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.58B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track V Square Quantitative Management LLC Portfolio

Follow V Square Quantitative Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V Square Quantitative Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Square Quantitative Management LLC with notifications on news.